{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:29:34Z","timestamp":1791142174466,"version":"4.1.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1208\/aapsj070371","type":"journal-article","created":{"date-parts":[[2006,1,6]],"date-time":"2006-01-06T17:44:02Z","timestamp":1136569442000},"page":"E704-E722","source":"Crossref","is-referenced-by-count":89,"title":["Kappa opioid antagonists: Past successes and future prospects"],"prefix":"10.1208","volume":"7","author":[{"given":"Matthew D.","family":"Metcalf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Coop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"73704_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0014-5793(94)80368-4","volume":"338","author":"JB Wang","year":"1994","unstructured":"Wang JB, Johnson PS, Persico AM, Hawkins AL, Griffin CA, Uhl GR. Human mu opiate receptor\u2014cDNA and genomic clones, pharmacologic characterization and chromosomal assignment.FEBS Lett. 1994;338:217\u2013222.","journal-title":"FEBS Lett"},{"key":"73704_CR2","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1006\/bbrc.1994.2091","volume":"202","author":"E Mansson","year":"1994","unstructured":"Mansson E, Bare L, Yang D. Isolation of a human kappa opioid receptor cDNA from placenta.Biochem Biophys Res Commun. 1994;202:1431\u20131434.","journal-title":"Biochem Biophys Res Commun"},{"key":"73704_CR3","doi-asserted-by":"publisher","first-page":"12048","DOI":"10.1073\/pnas.89.24.12048","volume":"89","author":"BL Kieffer","year":"1992","unstructured":"Kieffer BL, Befort K, Gavriaux-Ruff C, Hirth CG. The opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization.Proc Natl Acad Sci USA. 1992;89:12048\u201312052.","journal-title":"Proc Natl Acad Sci USA"},{"key":"73704_CR4","first-page":"130","volume":"45","author":"GR Peters","year":"1989","unstructured":"Peters GR, Gaylor S. Human central nervous system (CNS) effects of a selective kappa opioid agonist [abstract].Clin Pharmacol Ther. 1989;45:130.","journal-title":"Clin Pharmacol Ther."},{"key":"73704_CR5","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-0585-7","volume-title":"Opioid Analgesics","author":"AF Casy","year":"1986","unstructured":"Casy AF, Parfitt RT.Opioid Analgesics New York and London: Plenum Press; 1986."},{"key":"73704_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0079-6468(08)70035-3","volume":"35","author":"H Schmidhammer","year":"1998","unstructured":"Schmidhammer H. Opioid receptor antagonists.Prog Med Chem. 1998;35:83\u2013132.","journal-title":"Prog Med Chem."},{"key":"73704_CR7","first-page":"481","volume":"13","author":"A Coop","year":"2000","unstructured":"Coop A, Rice KC. Role of delta-opioid receptors in biological processes.Drug News Perspect. 2000;13:481\u2013487.","journal-title":"Drug News Perspect."},{"key":"73704_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0079-6468(08)70006-7","volume":"29","author":"DC Rees","year":"1992","unstructured":"Rees DC. Chemical structures and biological activities of nonpeptide selective kappa opioid ligands.Prog Med Chem. 1992;29:109\u2013139.","journal-title":"Prog Med Chem."},{"key":"73704_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0014-2999(98)00637-2","volume":"358","author":"AV Kuzmin","year":"1998","unstructured":"Kuzmin AV, Gerrits MAFM, Van Ree JM. Kappa-opioid receptor blockade with nor-binaltorphimine modulates cocaine self-administration in drug-na\u00efve rats.Eur J Pharmacol. 1998;358:197\u2013202.","journal-title":"Eur J Pharmacol."},{"key":"73704_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1124\/jpet.102.046433","volume":"305","author":"SD Mague","year":"2003","unstructured":"Mague SD, Pliakas AM, Todtenkopf MS, et al. Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats.J Pharmacol Exp Ther. 2003;305:323\u2013330.","journal-title":"J Pharmacol Exp Ther."},{"key":"73704_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0006-8993(01)02624-5","volume":"909","author":"DC Jewett","year":"2001","unstructured":"Jewett DC, Grace MK, Jones RM, Billington CJ, Portoghese PS, Levine AS. The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol-and neuropeptide-Y-induced feeding in rats.Brain Res. 2001;909:75\u201380.","journal-title":"Brain Res."},{"key":"73704_CR12","doi-asserted-by":"publisher","first-page":"11934","DOI":"10.1073\/pnas.182234399","volume":"99","author":"BL Roth","year":"2002","unstructured":"Roth BL, Baner K, Westkaemper R, et al. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.Proc Natl Acad Sci USA. 2002;99:11934\u201311939.","journal-title":"Proc Natl Acad Sci USA"},{"key":"73704_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0079-6468(08)70035-3","volume":"35","author":"H Schmidhammer","year":"1998","unstructured":"Schmidhammer H. Opioid receptor antagonists.Prog Med Chem. 1998;35:83\u2013132.","journal-title":"Prog Med Chem."},{"key":"73704_CR14","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1021\/jm025575g","volume":"45","author":"MA Bennett","year":"2002","unstructured":"Bennett MA, Murray TF, Aldrich JV. Identification of arodyn, a novel acetylated dynorphin A-(1\u201311) analogue, as a \u03ba opioid receptor antagonist.J Med Chem. 2002;45:5617\u20135619.","journal-title":"J Med Chem."},{"key":"73704_CR15","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1016\/j.bmcl.2004.06.077","volume":"14","author":"G Weltrowska","year":"2004","unstructured":"Weltrowska G, Lu Y, Lemieux C, Chung NN, Schiller PW. A novel cyclic enkephalin analogue with potent opioid antagonist activity.Bioorg Med Chem Lett. 2004;14:4731\u20134733.","journal-title":"Bioorg Med Chem Lett."},{"key":"73704_CR16","first-page":"329","volume-title":"Burger\u2019s Medicinal Chemistry and Drug Discovery, Volume 6, Nervous System Agents","author":"JV Aldrich","year":"2003","unstructured":"Aldrich JV. Analgesics. In: Abraham DJ, ed.Burger\u2019s Medicinal Chemistry and Drug Discovery, Volume 6, Nervous System Agents. 6th ed. New York: John Wiley and Sons; 2003:329\u2013482.","edition":"6th ed."},{"key":"73704_CR17","volume-title":"Buprenorphine: Combatting Drug Abuse with a Unique Opioid","author":"A Cowan","year":"1995","unstructured":"Cowan A, Lewis JW.Buprenorphine: Combatting Drug Abuse with a Unique Opioid. New York: John Wiley and Sons; 1995."},{"key":"73704_CR18","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/S0165-6147(00)01799-5","volume":"22","author":"LA Devi","year":"2001","unstructured":"Devi LA. Heterodimerization of G-protein-coupled receptors: pharmacology, signaling, and trafficking.Trends Pharmacol Sci. 2001;22:532\u2013537.","journal-title":"Trends Pharmacol Sci."},{"key":"73704_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejphar.2003.11.078","volume":"485","author":"DE Rusovici","year":"2004","unstructured":"Rusovici DE, Negus SS, Mello NK, Bidlack JM. \u03ba-opioid receptors are differentially labeled by arylacetamides and benzomorphans.Eur J Pharmacol. 2004;485:119\u2013125.","journal-title":"Eur J Pharmacol."},{"key":"73704_CR20","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1021\/jm00165a002","volume":"33","author":"DM Zimmerman","year":"1990","unstructured":"Zimmerman DM, Leander JD. Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents.J Med Chem. 1990;33:895\u2013902.","journal-title":"J Med Chem."},{"key":"73704_CR21","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1021\/jm000059g","volume":"43","author":"DL Larson","year":"2000","unstructured":"Larson DL, Jones RM, Hjorth SA, Schwartz TW, Portoghese PS. Binding of norbinaltorphimine (norBNI) congeners to wild-type and mutant mu and kappa opioid receptors: molecular recognition loci for the pharmacophore and address components of kappa antagonists.J Med Chem. 2000;43:1573\u20131576.","journal-title":"J Med Chem."},{"key":"73704_CR22","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1021\/jm9805182","volume":"41","author":"RM Jones","year":"1998","unstructured":"Jones RM, Hjorth SA, Schwartz TW, Portoghese PS. Mutational evidence for a common \u03ba antagonist binding pocket in the wild-type \u03ba and mutant \u03bc[K303E] opioid receptors.J Med Chem. 1998;41:4911\u20134914.","journal-title":"J Med Chem."},{"key":"73704_CR23","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1021\/jm010095v","volume":"44","author":"SK Sharma","year":"2001","unstructured":"Sharma SK, Jones RM, Metzger TG, Ferguson DM, Portoghese PS. Transformation of a \u03ba-opioid receptor antagonist to a \u03ba-agonist by transfer of a guanidinium group form the 5\u2032-to the 6\u2032-position of naltrindole.J Med Chem. 2001;44:2073\u20132079.","journal-title":"J Med Chem."},{"key":"73704_CR24","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1021\/jm0000665","volume":"43","author":"WC Stevens","year":"2000","unstructured":"Stevens WC, Jones RM, Subramanian G, Metzger TG, Ferguson DM, Portoghese PS. Potent and selective indolomorphinan antagonists of the kappa-opioid receptor.J Med Chem. 2000;43:2759\u20132769.","journal-title":"J Med Chem."},{"key":"73704_CR25","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1021\/jm000381r","volume":"44","author":"TG Metzger","year":"2001","unstructured":"Metzger TG, Paterlini MG, Ferguson DM, Portoghese PS. Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site directed mutagenesis of opioid receptors: exploring the \u2018address\u2019 recognition locus.J Med Chem. 2001;44:857\u2013862.","journal-title":"J Med Chem."},{"key":"73704_CR26","doi-asserted-by":"publisher","first-page":"8042","DOI":"10.1073\/pnas.91.17.8042","volume":"91","author":"H Kong","year":"1994","unstructured":"Kong H, Raynor K, Yano H, Takeda J, Bell GI, Reisine T. Agonists and antagonists bind to different domanins of the cloned \u03ba opioid receptor.Proc Natl Acad Sci USA. 1994;91:8042\u20138046.","journal-title":"Proc Natl Acad Sci USA"},{"key":"73704_CR27","first-page":"1089","volume":"47","author":"SA Hjorth","year":"1995","unstructured":"Hjorth SA, Thirstrup K, Grandy DK, Schwartz TW. Analysis of selective binding epitopes for the \u03ba-opioids receptor antagonist nor-binaltorphimine.Mol Pharmacol. 1995;47:1089\u20131094.","journal-title":"Mol Pharmacol."},{"key":"73704_CR28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/med.10059","volume":"24","author":"M Eguchi","year":"2004","unstructured":"Eguchi M. Recent Advances in selective opioid receptor agonists and antagonists.Med Res Rev. 2004;24:182\u2013212.","journal-title":"Med Res Rev."},{"key":"73704_CR29","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/0024-3205(87)90585-6","volume":"40","author":"PS Portoghese","year":"1987","unstructured":"Portoghese PS, Lipkowski AW, Takemori AE. Binaltorphimine and nor-binaltorphimine, potent and selective \u03ba-opioid receptor antagonists.Life Sci. 1987;40:1287\u20131292.","journal-title":"Life Sci."},{"key":"73704_CR30","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s00213-003-1638-0","volume":"172","author":"ER Butelman","year":"2004","unstructured":"Butelman ER, Harris TJ, Kreek MJ. The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys.Psychopharmacology (Berl). 2004;172:220\u2013224.","journal-title":"Psychopharmacology (Berl)"},{"key":"73704_CR31","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1021\/jm00349a016","volume":"25","author":"M Erez","year":"1982","unstructured":"Erez M, Takemori AE, Portoghese PS. Narcotic antagonistic potency of bivalent ligands which contain \u03b2-naltrexamine. Evidence for bridging between proximal recognition sites.J Med Chem. 1982;25:847\u2013849.","journal-title":"J Med Chem."},{"key":"73704_CR32","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/0024-3205(85)90202-4","volume":"36","author":"PS Portoghese","year":"1985","unstructured":"Portoghese PS, Takemori AE. TENA, a selective kappa opioid receptor antagonist.Life Sci. 1985;36:801\u2013805.","journal-title":"Life Sci."},{"key":"73704_CR33","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1021\/jm00155a048","volume":"29","author":"S Botros","year":"1986","unstructured":"Botros S, Lipkowski AW, Takemori AE, Portoghese PS. Investigation of the structural requirements for the \u03ba-selective opioid receptor antagonist, 6\u03b2,6\u03b2\u2032-[ethlenebis(oxyethyleneimino)]bis[17-(cyclopropylmethyl)-4,5\u03b1-epoxymorphinan-3,14-diol] (TENA).J Med Chem. 1986;29:874\u2013876.","journal-title":"J Med Chem."},{"key":"73704_CR34","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1021\/jm00159a014","volume":"29","author":"PS Portoghese","year":"1986","unstructured":"Portoghese PS, Ronsisvalle G, Larson DL, Takemori AE. Synthesis and opioid antagonist potencies of naltrexamine bivalent ligands with conformationally restricted spacers.J Med Chem. 1986;29:1650\u20131653.","journal-title":"J Med Chem."},{"key":"73704_CR35","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1021\/jm00160a010","volume":"29","author":"PS Portoghese","year":"1986","unstructured":"Portoghese PS, Larson DL, Sayre LM, et al. Opioid agonist and antagonist bivalent ligands. The relationship between spacer length and selectivity at multiple opioid receptors.J Med Chem. 1986;29:1855\u20131861.","journal-title":"J Med Chem."},{"key":"73704_CR36","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1021\/jm00385a002","volume":"30","author":"AS Portoghese","year":"1987","unstructured":"Portoghese AS, Lipkowski AW, Takemori AE. Bimorphinans as highly selective, potent \u03ba opioid receptor antagonists.J Med Chem. 1987;30:238\u2013239.","journal-title":"J Med Chem."},{"key":"73704_CR37","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev.pa.32.040192.001323","volume":"32","author":"AE Takemori","year":"1992","unstructured":"Takemori AE, Portoghese PS. Selective naltrexone-derived opioid receptor antagonists.Annu Rev Pharmacol Toxicol. 1992;32:239\u2013269.","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"73704_CR38","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/0165-6147(89)90267-8","volume":"10","author":"PS Portoghese","year":"1989","unstructured":"Portoghese PS. Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists.Trends Pharmacol Sci. 1989;10:230\u2013235.","journal-title":"Trends Pharmacol Sci."},{"key":"73704_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1749-6632.1977.tb41843.x","volume":"297","author":"R Schwyzer","year":"1977","unstructured":"Schwyzer R. ACTH: a short introductory review.Ann NY Acad Sci. 1977;297:3\u201326.","journal-title":"Ann NY Acad Sci."},{"key":"73704_CR40","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1021\/jm00068a020","volume":"36","author":"C Lin","year":"1993","unstructured":"Lin C, Takemori AE, Portoghese PS. Synthesis and \u03ba-opioid antagonist selectivity of a norbinaltorphimine congener. Identification of the address moiety reqired for \u03ba-antagonist activity.J Med Chem. 1993;36:2412\u20132415.","journal-title":"J Med Chem."},{"key":"73704_CR41","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1021\/jm030094y","volume":"46","author":"JB Thomas","year":"2003","unstructured":"Thomas JB, Atkinson RN, Vinson A, et al. Identification of (3R)-7-Hydroxy-N-((1S)-1-{[(3R, 4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide as a novel potent and selective opioid \u03ba receptor antagonist.J Med Chem. 2003;46:3127\u20133137.","journal-title":"J Med Chem."},{"key":"73704_CR42","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1021\/jm040807s","volume":"47","author":"P Grundt","year":"2004","unstructured":"Grundt P, Williams IA, Lewis JW, Husbands SM. Identification of a new scaffold for \u03ba opioid receptor antagonism based on the 2-amino-1, 1-dimethyl-7-hydroxytetralin pharmacophore.J Med Chem. 2004;47:5069\u20135075.","journal-title":"J Med Chem."},{"key":"73704_CR43","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1021\/jm00402a015","volume":"31","author":"PS Portoghese","year":"1988","unstructured":"Portoghese PS, Nagase H, Takemori AE. Only one pharmacophore is required for the \u03ba opioid antagonist selectivity of norbinaltorphimine.J Med Chem. 1988;31:1344\u20131347.","journal-title":"J Med Chem."},{"key":"73704_CR44","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1021\/jm00399a026","volume":"31","author":"PS Portoghese","year":"1988","unstructured":"Portoghese PS, Nagase H, Lipkowski AW, Larson DL, Takemori AE. Binaltorphimine-related bivalent ligands and their \u03ba opioid receptor antagonist selectivity.J Med Chem. 1988;31:836\u2013841.","journal-title":"J Med Chem."},{"key":"73704_CR45","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/hlca.19900730622","volume":"73","author":"H Schmidhammer","year":"1990","unstructured":"Schmidhammer H, Ganglbauer E, Mitterdorfer J, Rollinger JM, Smith CFC. Synthesis and biological evaluation of 14-alkoxymorphinans 14,14\u2032-dimethoxy analogues of norbinaltorphimine: synthesis and determination of their \u03ba opioid antagonist selectivity.Helv Chim Acta. 1990;73:1779\u20131783.","journal-title":"Helv Chim Acta."},{"key":"73704_CR46","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/hlca.19890720408","volume":"72","author":"H Schmidhammer","year":"1989","unstructured":"Schmidhammer H, Smith CFC. A simple and efficient method for the preparation of binaltorphimine and derivatives and determination of their \u03ba opioid antagonist selectivity.Helv Chim Acta. 1989;72:675\u2013677.","journal-title":"Helv Chim Acta"},{"key":"73704_CR47","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1021\/jm00108a008","volume":"34","author":"PS Portoghese","year":"1991","unstructured":"Portoghese PS, Garzon-Aburbeh A, Nagase H, Lin C, Takemori AE. Role of the spacer in conferring \u03ba opioid receptor selectivity to bivalent ligands related to norbinaltorphimine.J Med Chem. 1991;34:1292\u20131296.","journal-title":"J Med Chem."},{"key":"73704_CR48","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1021\/jm00036a015","volume":"37","author":"PS Portoghese","year":"1994","unstructured":"Portoghese PS, Lin C, Farouz-Grant R, Takemori AE. Structure-activity relationship of N17\u2032substituted norbinaltorphimine congeners. Role of the N17\u2032 basic group in the interaction with a putative address subsite on the \u03ba opioid receptor.J Med Chem. 1994;37:1495\u20131500.","journal-title":"J Med Chem."},{"key":"73704_CR49","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1021\/jm030467v","volume":"47","author":"JB Thomas","year":"2004","unstructured":"Thomas JB, Fix SE, Rothman RB, et al., Importance of phenolic address groups in opioid kappa receptor selective antagonists.J Med Chem. 2004;47:1070\u20131073.","journal-title":"J Med Chem."},{"key":"73704_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0024-3205(99)00560-3","volume":"66","author":"A Marki","year":"2000","unstructured":"Marki A, Otvos F, Toth G, Hosztafi S, Borsodi A. Tritiated kappa receptor antagonist norbinaltorphimine: synthesis and in vitro binding in three different tissues.Life Sci. 2000;66:43\u201349.","journal-title":"Life Sci."},{"key":"73704_CR51","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1021\/jm00053a025","volume":"36","author":"SL Olmsted","year":"1993","unstructured":"Olmsted SL, Takemori AE, Portoghese PS. A remarkable change of opioid receptor selectivity on the attachment of a peptidomimetic \u03ba address element to the \u03b4 antagonist, naltrindole: 5\u2032-[(N2-alkylamidino) methyl]naltrindole derivatives as a novel class of \u03ba opioid receptor antagonists.J Med Chem. 1993;36:179\u2013180.","journal-title":"J Med Chem."},{"key":"73704_CR52","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0014-2999(00)00208-9","volume":"396","author":"RM Jones","year":"2000","unstructured":"Jones RM, Portoghese PS. 5\u2032-Guanidinonaltrindole, a highly selective and potent \u03ba-opioid receptor antagonist.Eur J Pharmacol. 2000;396:49\u201352.","journal-title":"Eur J Pharmacol."},{"key":"73704_CR53","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/S0960-894X(00)00433-9","volume":"10","author":"AR Jales","year":"2000","unstructured":"Jales AR, Husbands SM, Lewis JW. Selective \u03ba-opioid antagonists related to naltrindole. Effect of side-chain spacer in the 5\u2032-amidinoalkyl series.Bioorg Med Chem Lett. 2000;10:2259\u20132261.","journal-title":"Bioorg Med Chem Lett."},{"key":"73704_CR54","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1021\/jm020997b","volume":"46","author":"SL Black","year":"2003","unstructured":"Black SL, Jales AR, Brandt W, Lewis JW, Husbands SM. The role of the side chain in determining relative \u03b4- and \u03ba-affinity in C5\u2032-substituted analogues of naltrindole.J Med Chem. 2003;46:314\u2013317.","journal-title":"J Med Chem."},{"key":"73704_CR55","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1021\/jm0309203","volume":"46","author":"SL Black","year":"2003","unstructured":"Black SL, Chauvignac C, Grundt P, et al. Guanidino N-substituted and N,N-disubstituted derivatives of the \u03ba-opioid antagonist GNTI.J Med Chem. 2003;46:5505\u20135511.","journal-title":"J Med Chem."},{"key":"73704_CR56","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0960-894X(02)00934-4","volume":"13","author":"S Ananthan","year":"2003","unstructured":"Ananthan S, Kezar HS, Saini SK, et al. Synthesis, opioid receptor binding, and functional activity of 5\u2032-subsitituted 17-cycloprop ylmethylpyrido[2\u2032,3\u2032,:6,7]morphinans.Bioorg Med Chem Lett. 2003;13:529\u2013532.","journal-title":"Bioorg Med Chem Lett."},{"key":"73704_CR57","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1021\/jm015521r","volume":"44","author":"JB Thomas","year":"2001","unstructured":"Thomas JB, Atkinson RN, Rothman RB, et al. Identification of the firsttrans-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid \u03ba receptor antagonist activity.J Med Chem. 2001;44:2687\u20132690.","journal-title":"J Med Chem."},{"key":"73704_CR58","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1021\/jm00072a001","volume":"36","author":"DM Zimmerman","year":"1993","unstructured":"Zimmerman DM, Leander JD, Cantrell BE, et al. Structure-activity relationships oftrans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine antagonists for \u03bc- and \u03ba-opioid receptors.J Med Chem. 1993;36:2833\u20132841.","journal-title":"J Med Chem."},{"key":"73704_CR59","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1021\/jm980511k","volume":"41","author":"JB Thomas","year":"1998","unstructured":"Thomas JB, Fall MJ, Cooper JB, et al. Identification of an opioid \u03ba receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine.J Med Chem. 1998;41:5188\u20135197.","journal-title":"J Med Chem."},{"key":"73704_CR60","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1021\/jm020084h","volume":"45","author":"JB Thomas","year":"2002","unstructured":"Thomas JB, Atkinson RN, Namdev N, et al. Discovery of an opioid \u03ba receptor selective pure antagonist from a library of N-substituted 4\u03b2-methyl-5-(3-hydroxyphenyl)morphans.J Med Chem. 2002;45:3524\u20133530.","journal-title":"J Med Chem."},{"key":"73704_CR61","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1021\/jm040807s","volume":"47","author":"P Grundt","year":"2004","unstructured":"Grundt P, Williams IA, Lewis JW, Husbands SM. Identification of a new scaffold for opioid receptor antagonism based on the 2-amino-1, 1-dimethyl-7-hydroxytetralin pharmacophore.J Med Chem. 2004;47:5069\u20135075.","journal-title":"J Med Chem."},{"key":"73704_CR62","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/0014-5793(89)80619-2","volume":"249","author":"BR Costa de","year":"1989","unstructured":"de Costa BR, Band L, Rothman RB, et al. Synthesis of an affinity ligand (\u2018UPHIT\u2019) for in vivo acylation of the \u03ba-opioid receptor.FEBS Lett. 1989;249:178\u2013182.","journal-title":"FEBS Lett."},{"key":"73704_CR63","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/jm00122a001","volume":"32","author":"BR Costa de","year":"1989","unstructured":"de Costa BR, Rothman RB, Bykov V, Jacobson AE, Rice KC. Selective and enantiospecific acylation of \u03ba opioid receptors by (1S,2S)-trans-2-isothiocyanato-N-methyl-N-[2-(1-pyrrolidinyl)cyclohecyl]benze neacetamide. Demonstration of \u03ba receptor heterogeneity.J Med Chem. 1989;32:281\u2013283.","journal-title":"J Med Chem."},{"key":"73704_CR64","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1021\/jm00037a001","volume":"37","author":"AC Chang","year":"1994","unstructured":"Chang AC, Takemori AE, Portoghese PS. 2-(3,4-dichlorophenyl)-N-methyl-N-[(1S)-1-(3-isothiocyanatophenyl)-2-(1-pyrrolidinyl)ethyl]acet amide: an opioid receptor affinity label that produces selective and long-lasting \u03ba antagonism in mice.J Med Chem. 1994;37:1547\u20131549.","journal-title":"J Med Chem."},{"key":"73704_CR65","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1021\/jm00037a001","volume":"37","author":"AC Chang","year":"1994","unstructured":"Chang AC, Takemori AE, Ojala WH, Gleason WB, Portoghese PS. \u03ba opioid receptor selective affinity labels: electrophilic benzeneacetamides as \u03ba-selective opioid antagonists.J Med Chem. 1994;37:1547\u20131549.","journal-title":"J Med Chem."},{"key":"73704_CR66","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1021\/jm049172n","volume":"48","author":"C Chauvignac","year":"2005","unstructured":"Chauvignac C, Miller CN, Srivastava SK, Lewis JW, Husbands SM, Taynor JR. Major effect of pyrrolic N-benzylation in norbinaltorphiminie, the selective \u03ba-opioid receptor antagonist.J Med Chem. 2005;48:1676\u20131679.","journal-title":"J Med Chem."},{"key":"73704_CR67","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00213-002-1038-x","volume":"163","author":"SS Negus","year":"2002","unstructured":"Negus SS, Mello NK, Linsenmayer DC, Jones RM, Portoghese PS. Kappa opioid antagonist effects of the novel kappa antagonist 5\u2032-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.Psychopharmacology (Berlin). 2002;163:412\u2013419.","journal-title":"Psychopharmacology (Berlin)"},{"key":"73704_CR68","first-page":"591","volume":"243","author":"AJ Bertalmio","year":"1987","unstructured":"Bertalmio AJ, Woods JH. Differentiation betweenmu andkappa receptor-mediated effects in opioid drug discrimination: apparent pA2 analysis.J Pharmacol Exp Ther. 1987;243:591\u2013597.","journal-title":"J Pharmacol Exp Ther."},{"key":"73704_CR69","first-page":"1025","volume":"270","author":"SS Negus","year":"1994","unstructured":"Negus SS, Butelman ER, Chang KJ, DeCosta B, Winger G, Woods JH. Behavioral effects of the systemically activedelta opioid agonist BW373U86 in rhesus monkeys.J Pharmacol Exp Ther. 1994;270:1025\u20131034.","journal-title":"J Pharmacol Exp Ther."},{"key":"73704_CR70","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejphar.2004.08.028","volume":"501","author":"I Carroll","year":"2004","unstructured":"Carroll I, Thomas JB, Dykstra LA, et al. Pharmacological properties of JDTic: a novel \u03ba-opioid receptor antagonist.Eur J Pharmacol. 2004;501:111\u2013119.","journal-title":"Eur J Pharmacol."},{"key":"73704_CR71","first-page":"1269","volume":"267","author":"ER Butelman","year":"1993","unstructured":"Butelman ER, Negus SS, Ai Y, deCosta BR, Woods JH. Kappa opioid antagonist effects of systemically administered norbinaltorphimine in a thermal antinociception assay in rhesus monkeys.J Pharmacol Exp Ther. 1993;267:1269\u20131276.","journal-title":"J Pharmacol Exp Ther."},{"key":"73704_CR72","first-page":"30","volume":"316","author":"T Endoh","year":"1992","unstructured":"Endoh T, Matsuura H, Tanaka C, Nagase H. Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo.Arch Int Pharmacodyn Ther. 1992;316:30\u201342.","journal-title":"Arch Int Pharmacodyn Ther."},{"key":"73704_CR73","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/BF02245071","volume":"115","author":"JH Broadbear","year":"1994","unstructured":"Broadbear JH, Negus SS, Butelman ER, de Costa BR, Woods JH. Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay.Psychopharmacology (Berlin). 1994;115:311\u2013319.","journal-title":"Psychopharmacology (Berlin)"},{"key":"73704_CR74","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1124\/jpet.102.044909","volume":"305","author":"MCH Ko","year":"2003","unstructured":"Ko MCH, Lee H, Song MS, et al. Activation of \u03ba-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys.J Pharmacol Exp Ther. 2003;305:173\u2013179.","journal-title":"J Pharmacol Exp Ther."},{"key":"73704_CR75","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0014-2999(92)90055-9","volume":"215","author":"DNC Jones","year":"1992","unstructured":"Jones DNC, Holtzman SG. Long term kappa opioid receptor blockade following nor-binaltorphimine.Eur J Pharmacol. 1992;215:345\u2013348.","journal-title":"Eur J Pharmacol."},{"key":"73704_CR76","first-page":"1237","volume":"260","author":"P Horan","year":"1992","unstructured":"Horan P, Taylor J, Yamamura HI, Porreca F. Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test.J Pharmacol Exp Ther. 1992;260:1237\u20131243.","journal-title":"J Pharmacol Exp Ther."},{"key":"73704_CR77","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0022-3565(24)35216-4","volume":"291","author":"MCH Ko","year":"1999","unstructured":"Ko MCH, Johnson MD, Butelman ER, Willmont KJ, Mosberg HI, Woods JH. Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys.J Pharmacol Exp Ther. 1999;291:1113\u20131120.","journal-title":"J Pharmacol Exp Ther."},{"key":"73704_CR78","first-page":"815","volume":"6","author":"DC Jewett","year":"1995","unstructured":"Jewett DC, Woods JH. Nor-binaltorphimine: a very, very long acting kappa opioid antagonist in pigeons.Behav Pharmacol. 1995;6:815\u2013820.","journal-title":"Behav Pharmacol."},{"key":"73704_CR79","first-page":"255","volume":"246","author":"AE Takemori","year":"1988","unstructured":"Takemori AE, Ho BY, Naeseth JS, Portoghese PS. Norbinaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays.J Pharmacol Exp Ther. 1988;246:255\u2013258.","journal-title":"J Pharmacol Exp Ther."},{"key":"73704_CR80","first-page":"971","volume":"247","author":"AE Takemori","year":"1988","unstructured":"Takemori AE, Schwartz MM, Portoghese PS. Suppression by norbinaltorphimine ofkappa opioid-mediated diuresis in rats.J Pharmacol Exp Ther. 1988;247:971\u2013974.","journal-title":"J Pharmacol Exp Ther."},{"key":"73704_CR81","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0006-8993(03)02938-X","volume":"982","author":"MCH Ko","year":"2003","unstructured":"Ko MCH, Willmont KJ, Lee H, Flory GS, Woods JH. Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys.Brain Res. 2003;982:38\u201344.","journal-title":"Brain Res."},{"key":"73704_CR82","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1126\/science.282.5397.2272","volume":"282","author":"WA Carlezon","year":"1998","unstructured":"Carlezon WA Jr, Thome J, Olson VG, et al. Regulation of cocaine reward by CREB.Science. 1998;282:2272\u20132275.","journal-title":"Science"},{"key":"73704_CR83","doi-asserted-by":"crossref","first-page":"7397","DOI":"10.1523\/JNEUROSCI.21-18-07397.2001","volume":"21","author":"AM Pliakas","year":"2001","unstructured":"Pliakas AM, Carlson RR, Neve RL, Konradi C, Nestler EJ, Carlexon WA. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accum bens.J Neurosci. 2001;21:7397\u20137403.","journal-title":"J Neurosci."},{"key":"73704_CR84","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1523\/JNEUROSCI.23-13-05674.2003","volume":"23","author":"JP McLaughlin","year":"2003","unstructured":"McLaughlin JP, Marton-Popovici M, Chavkin C. \u03ba opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses.J Neurosci. 2003;23:5674\u20135683.","journal-title":"J Neurosci."},{"key":"73704_CR85","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.neulet.2004.03.041","volume":"363","author":"E Berrocoso","year":"2004","unstructured":"Berrocoso E, Rojas-Corrales MO, Mico JA. Non-selective opioid receptor antagonism of the antidepressant-like effect of venlafaxine in the forced swimming test in mice.Neurosci Lett. 2004;363:25\u201328.","journal-title":"Neurosci Lett."},{"key":"73704_CR86","doi-asserted-by":"crossref","first-page":"10883","DOI":"10.1523\/JNEUROSCI.22-24-10883.2002","volume":"22","author":"SS Newton","year":"2002","unstructured":"Newton SS, Thome J, Wallace TL, et al. Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accum bens produces an antidepressant-like effect.J Neurosci. 2002;22:10883\u201310890.","journal-title":"J Neurosci."},{"key":"73704_CR87","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1111\/j.1471-4159.2004.02589.x","volume":"90","author":"Y Shirayama","year":"2004","unstructured":"Shirayama Y, Ishida H, Iwata M, Hazama G, Kawahara R, Duman RS. Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects.J Neurochem. 2004;90:1258\u20131268.","journal-title":"J Neurochem."},{"key":"73704_CR88","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0014-2999(01)00941-4","volume":"418","author":"J Kamei","year":"2001","unstructured":"Kamei J, Nagase H. Norbinaltorphimine, a selective \u03ba opioid receptor antagonist, induces an itch-associated response in mice.Eur J Pharmacol. 2001;418:141\u2013145.","journal-title":"Eur J Pharmacol."},{"key":"73704_CR89","first-page":"A51","volume":"44","author":"A Cowan","year":"2002","unstructured":"Cowan A, Inan S, Kehner GB. GNTI, a kappa receptor antagonist, causes compulsive scratching in mice.The Pharmacologist. 2002;44:A51.","journal-title":"The Pharmacologist."},{"key":"73704_CR90","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0014-2999(01)01588-6","volume":"435","author":"Y Togashi","year":"2002","unstructured":"Togashi Y, Umeuchi H, Okano K, et al. Antipruritic activity of the \u03ba-opioid receptor agonist, TRK-820.Eur J Pharmacol. 2002;435:259\u2013264.","journal-title":"Eur J Pharmacol."},{"key":"73704_CR91","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1124\/jpet.102.044909","volume":"305","author":"MCH Ko","year":"2003","unstructured":"Ko MCH, Lee H, Song MS, et al. Activation of \u03ba-opioid receptors inhibits pruritus evoked by subcutaneous of intrathecal administration of morphine in monkeys.J Pharmacol Exp Ther. 2003;305:173\u2013179.","journal-title":"J Pharmacol Exp Ther."},{"key":"73704_CR92","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejphar.2003.08.007","volume":"477","author":"H Umeuchi","year":"2003","unstructured":"Umeuchi H, Togashi Y, Honda T, et al. Involvement of central \u03bc-opioid system in the scratching behavior in mice, and the suppression of it by the activation of \u03ba-opioid system.Eur J Pharmacol. 2003;477:29\u201335.","journal-title":"Eur J Pharmacol."},{"key":"73704_CR93","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/0006-8993(94)91239-4","volume":"637","author":"AS Levine","year":"1994","unstructured":"Levine AS, Grace M, Portoghese PS, Billington CJ. The effect of selective opioid antagonists on butorphanol-induced feeding.Brain Res. 1994;637:242\u2013248.","journal-title":"Brain Res."},{"key":"73704_CR94","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/S0196-9781(97)00074-0","volume":"18","author":"JL Cole","year":"1997","unstructured":"Cole JL, Berman N, Bodnar RJ. Evaluation of chronic opioid receptor antagonist effects upon weight and intake measures in lean and obese zucker rats.Peptides. 1997;18:1201\u20131207.","journal-title":"Peptides"},{"key":"73704_CR95","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0006-8993(95)00957-R","volume":"700","author":"RJ Bodnar","year":"1995","unstructured":"Bodnar RJ, Glass MJ, Ragnauth A, Cooper ML. General, \u03bc and \u03ba opioid antagonists in the nucleus accum bens alter food intake under deprivation, glucoprivic and palatable conditions.Brain Res. 1995;700:205\u2013212.","journal-title":"Brain Res."},{"key":"73704_CR96","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0006-8993(95)00385-4","volume":"685","author":"L Leventhal","year":"1995","unstructured":"Leventhal L, Kirkham TC, Cole JL, Bodnar RJ. Selective actions of central \u03bc and \u03ba opioid antagonists upon sucrose intake in sham-fed rats.Brain Res. 1995;685:205\u2013210.","journal-title":"Brain Res."},{"key":"73704_CR97","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.brainres.2004.08.032","volume":"1026","author":"E Khaimova","year":"2004","unstructured":"Khaimova E, Kandov Y, Israel Y, Cataldo G, Hadjimarkou MM, Bodnar RJ. Opioid receptor subtype antagonists differentially alter GABA agonist-induced feeding elicited from either the nucleus accumbens shell or ventral tegmental area regions in rats.Brain Res. 2004;1026:284\u2013294.","journal-title":"Brain Res."},{"key":"73704_CR98","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0006-8993(93)91552-4","volume":"631","author":"CM Kotz","year":"1993","unstructured":"Kotz CM, Grace MK, Billington CJ, Levine AS. The effect of norbinaltorphimine, \u03b2-funaltrexamine and naltrindole on NPY-induced feeding.Brain Res. 1993;631:325\u2013328.","journal-title":"Brain Res."},{"key":"73704_CR99","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0091-3057(90)90206-W","volume":"35","author":"DJ Calcagnetti","year":"1990","unstructured":"Calcagnetti DJ, Calcagnetti RL, Fanselow MS. Centrally administered opioid antagonists, nor-binaltorphimine, 16-methyl cyprenorphine, and Mr2266, suppress intake of a sweet solution.Pharmacol Biochem Behav. 1990;35:69\u201373.","journal-title":"Pharmacol Biochem Behav."},{"key":"73704_CR100","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/0304-3940(93)90329-J","volume":"153","author":"R Spanagel","year":"1993","unstructured":"Spanagel R, Shippenberg TS. Modulation of morphine-induced sensitization by endogenous \u03ba opioid systems in the rat.Neurosci Lett. 1993;153:232\u2013236.","journal-title":"Neurosci Lett."},{"key":"73704_CR101","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0306-4530(02)00037-9","volume":"28","author":"KL Williams","year":"2003","unstructured":"Williams KL, Ko MHC, Rice KC, Woods JH. Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys.Psychoneuroendocrinology. 2003;28:513\u2013528.","journal-title":"Psychoneuroendocrinology"},{"key":"73704_CR102","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/sj.npp.1300527","volume":"30","author":"M Narita","year":"2005","unstructured":"Narita M, Kishimoto Y, Ise Y, Yajima Y, Misawa K, Suzuki T. Direct evidence for the involvement of the mesolimbic \u03ba-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state.Neuropsychopharmacology. 2005;30:111\u2013118.","journal-title":"Neuropsychopharmacology"},{"key":"73704_CR103","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nlm.2004.04.001","volume":"82","author":"RL Joynes","year":"2004","unstructured":"Joynes RL, Grau JW. Instrumental learning within the spinal cord: III. Prior exposure to noncontingent shock induces a behavioral deficit that is blocked by an opioid antagonist.Neurobiol Learn Mem. 2004;82:35\u201351.","journal-title":"Neurobiol Learn Mem."},{"key":"73704_CR104","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1111\/j.0953-816X.2004.03435.x","volume":"19","author":"HY Cheng","year":"2004","unstructured":"Cheng HY, Laviolette SR, van der Kooy D, Penninger JM. DREAM ablation selectively alters THC place aversion and analgesia but leaves intact the motivational and analgesic effects of morphine.Eur J Neurosci. 2004;19:3033\u20133041.","journal-title":"Eur J Neurosci."},{"key":"73704_CR105","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.neulet.2003.09.034","volume":"356","author":"H Mizoguchi","year":"2004","unstructured":"Mizoguchi H, Leitermann RJ, Narita M, Nagase H, Suzuki T, Tseng LF. Region-dependent G-protein activation by \u03ba-opioid receptor agonists in the mouse brain.Neurosci Lett. 2004;356:145\u2013147.","journal-title":"Neurosci Lett."},{"key":"73704_CR106","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/jnr.10578","volume":"72","author":"L Fan","year":"2003","unstructured":"Fan L, Tien L, Tanaka S, et al. Enhanced binding of norbinaltorphimine to \u03ba-opioid receptors in rats dependent on butorphanol.J Neurosci Res. 2003;72:781\u2013789.","journal-title":"J Neurosci Res."},{"key":"73704_CR107","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0304-3940(95)11757-N","volume":"194","author":"M Cosentino","year":"1995","unstructured":"Cosentino M, Marino F, DePonti F, et al. Tonic modulation of neurotransmitter release in the guinea-pig myenteric plexus: effect of \u03bc and \u03ba opioid receptor blockade and of chronic sympathetic denervation.Neurosci Lett. 1995;194:185\u2013188.","journal-title":"Neurosci Lett."},{"key":"73704_CR108","first-page":"784","volume":"277","author":"MH Ossipov","year":"1996","unstructured":"Ossipov MH, Kovelowski CJ, Wheeler-Aceto H, et al. Opioid antagonists and antisera to endogenous opioids increase the nociceptive response to formalin: demonstration of an opioidkappa anddelta inhibitory tone.J Pharmacol Exp Ther. 1996;277:784\u2013788.","journal-title":"J Pharmacol Exp Ther."},{"key":"73704_CR109","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/sj.bjp.0705427","volume":"140","author":"I Obara","year":"2003","unstructured":"Obara I, Mika J, Schafer MK-H, Przewlocka B. Antagonists of the \u03ba-opioid receptor enhance allodynia in rats and mice after sciatic nerve ligation.Br J Pharmacol. 2003;140:538\u2013546.","journal-title":"Br J Pharmacol."},{"key":"73704_CR110","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1124\/jpet.102.037655","volume":"302","author":"AK Baker","year":"2002","unstructured":"Baker AK, Meert TF. Functional effects of systemically administered agonists and antagonists of \u03bc, \u03b4, and \u03ba opioid receptor subtypes on body temperature in mice.J Pharmacol Exp Ther. 2002;302:1253\u20131264.","journal-title":"J Pharmacol Exp Ther."},{"key":"73704_CR111","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/0024-3205(89)90470-0","volume":"44","author":"FC Tortella","year":"1989","unstructured":"Tortella FC, Echevarria E, Lipkowski AW, Takemori AE, Portoghese PS, Holaday JW. Selective kappa antagonist properties of nor-binaltrophimine in the rat seizure model.Life Sci. 1989;44:661\u2013665.","journal-title":"Life Sci."},{"key":"73704_CR112","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/0024-3205(91)90451-G","volume":"48","author":"J Manzanares","year":"1991","unstructured":"Manzanares J, Lookingland KJ, LaVigne SD, Moore KE. Activation of tuberohypophysial dopamine neurons following intracerebroventricular administration of the selective kappa opioid receptor antagonist nor-binaltorphimine.Life Sci. 1991;48:1143\u20131149.","journal-title":"Life Sci."},{"key":"73704_CR113","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0014-2999(92)90649-O","volume":"210","author":"M McIntosh","year":"1992","unstructured":"McIntosh M, Kane K, Parratt J. Effects of selective opioid receptor agonists and antagonists during myocardial ischaemia.Eur J Pharmacol. 1992;210:37\u201344.","journal-title":"Eur J Pharmacol."},{"key":"73704_CR114","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0306-3623(96)00221-2","volume":"28","author":"F Llobel","year":"1997","unstructured":"Llobel F, Laorden ML. Effects of \u03bc-, \u03b4-, and \u03ba-opioid antagonists in atrial preparations from failing human hearts.Gen Pharmacol. 1997;28:371\u2013374.","journal-title":"Gen Pharmacol."},{"key":"73704_CR115","doi-asserted-by":"crossref","first-page":"H1032","DOI":"10.1152\/ajpheart.01004.2002","volume":"285","author":"Z Cao","year":"2003","unstructured":"Cao Z, Liu L, VanWinkle DM. Activation of \u03b4- and \u03ba-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels.Am J Physiol Heart Circ Physiol. 2003;285:H1032-H1039.","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"73704_CR116","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0022-3565(24)29530-6","volume":"297","author":"GJ Carey","year":"2001","unstructured":"Carey GJ, Bergman J. Enadoline discrimination in squirrel monkeys: effects of opioid agonists and antagonists.J Pharmacol Exp Ther. 2001;297:215\u2013223.","journal-title":"J Pharmacol Exp Ther."},{"key":"73704_CR117","first-page":"815","volume":"6","author":"DC Jewett","year":"1995","unstructured":"Jewett DC, Woods JH. Nor-binaltorphimine: an ultra-long acting kappa-opioid antagonist in pigeons.Behav Pharmacol. 1995;6:815\u2013820.","journal-title":"Behav Pharmacol."},{"key":"73704_CR118","first-page":"495","volume":"7","author":"MJ Picker","year":"1996","unstructured":"Picker MJ, Mathewson C, Allen RM. Opioids and rate of positively reinforced behavior: III. Antagonism by the long-lasting kappa antagonist norbinaltorphimine.Behav Pharmacol. 1996;7:495\u2013504.","journal-title":"Behav Pharmacol."}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/aapsj070371.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/aapsj070371\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/aapsj070371.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/aapsj070371","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T23:26:24Z","timestamp":1736205984000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/aapsj070371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":118,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["73704"],"URL":"https:\/\/doi.org\/10.1208\/aapsj070371","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}